Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Reports on Portola

Sort by

Portola: Management Guides to a Highly Probable US Launch of Bevyexxa in the December to February Timeframe (PTLA, Buy, $50.52)

Tuesday, November 7, 2017 · 11:43 am

Read More

Portola: Reiterating Buy and Refuting Recent Negative Blog by Adam F-stein (PTLA, Buy, $54.12)

Sunday, September 24, 2017 · 9:30 am

Read More

Portola: September 4 Conference Call Provides Update on Potential Launch Date for Bevyxxa and Announces Price (PTLA, Buy, $57.29)

Wednesday, September 6, 2017 · 10:18 am

Read More

Portola Pharmaceuticals: AndexXa BLA Resubmitted; Reiterating Buy (PTLA, $61.41, Buy)

Tuesday, August 8, 2017 · 12:45 pm

Read More

Portola Pharmaceuticals:  Betrixaban Approval Triggers Big Stock Move-Now What Do We Do? (PTLA, Buy, $55.42)

Thursday, June 29, 2017 · 9:09 am

Read More

Portola: Reiterating Buy Prior to June 24th PDUFA Date for Betrixaban (PTLA, Buy, $39.35)

Thursday, June 22, 2017 · 11:08 am

Read More

Portola Pharmaceuticals: Initiating Coverage with a Buy (PTLA, $40.05)

Thursday, May 4, 2017 · 10:47 am

Read More

There are 7 reports on file.

« Back to Company Reports Index